297 related articles for article (PubMed ID: 28108223)
21. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
Li JJ; Dong Z; Dawson MI; Colburn NH
Cancer Res; 1996 Feb; 56(3):483-9. PubMed ID: 8564958
[TBL] [Abstract][Full Text] [Related]
22. The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.
Ma C; Wang J; Gao Y; Gao TW; Chen G; Bower KA; Odetallah M; Ding M; Ke Z; Luo J
Cancer Res; 2007 Aug; 67(16):7756-64. PubMed ID: 17699780
[TBL] [Abstract][Full Text] [Related]
23. Pin1 is required for ultraviolet A-stimulated cyclooxygenase-2 induction in mouse epidermal cells.
Quyen BT; Choi HK; Kang KW
Cancer Lett; 2013 Jul; 335(1):31-40. PubMed ID: 23380442
[TBL] [Abstract][Full Text] [Related]
24. Early superoxide dismutase-sensitive event promotes neoplastic transformation in mouse epidermal JB6 cells.
Nakamura Y; Gindhart TD; Winterstein D; Tomita I; Seed JL; Colburn NH
Carcinogenesis; 1988 Feb; 9(2):203-7. PubMed ID: 2827903
[TBL] [Abstract][Full Text] [Related]
25. The effects of dissociated glucocorticoids RU24858 and RU24782 on TPA-induced skin tumor promotion biomarkers in SENCAR mice.
Kowalczyk P; Junco JJ; Kowalczyk MC; Sosnowska R; Tolstykh O; Walaszek Z; Hanausek M; Slaga TJ
Mol Carcinog; 2014 Jun; 53(6):488-97. PubMed ID: 23852815
[TBL] [Abstract][Full Text] [Related]
26. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis.
Hsu TC; Young MR; Cmarik J; Colburn NH
Free Radic Biol Med; 2000 May; 28(9):1338-48. PubMed ID: 10924853
[TBL] [Abstract][Full Text] [Related]
27. PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer.
Dong Z; Huang C; Ma WY
Anticancer Res; 1999; 19(5A):3743-7. PubMed ID: 10625951
[TBL] [Abstract][Full Text] [Related]
28. Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine.
Lee KW; Kang NJ; Heo YS; Rogozin EA; Pugliese A; Hwang MK; Bowden GT; Bode AM; Lee HJ; Dong Z
Cancer Res; 2008 Feb; 68(3):946-55. PubMed ID: 18245498
[TBL] [Abstract][Full Text] [Related]
29. Pro/antioxidant status and AP-1 transcription factor in murine skin following topical exposure to cumene hydroperoxide.
Murray AR; Kisin ER; Kommineni C; Vallyathan V; Castranova V; Shvedova AA
Carcinogenesis; 2007 Jul; 28(7):1582-8. PubMed ID: 17234724
[TBL] [Abstract][Full Text] [Related]
30. bcl-2 enhancement of malignant transformation in mouse epidermal JB6 cells.
Amstad PA; Liu H; Ichimiya M; Chang S; Berezesky IK; Trump BF
Mol Carcinog; 1997 Oct; 20(2):231-9. PubMed ID: 9364213
[TBL] [Abstract][Full Text] [Related]
31. Antioxidants inhibit the enhancement of malignant cell transformation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Wölfle D; Marquardt H
Carcinogenesis; 1996 Jun; 17(6):1273-8. PubMed ID: 8681442
[TBL] [Abstract][Full Text] [Related]
32. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells.
Su L; Mukherjee AB; Mukherjee BB
Oncogene; 1995 Jun; 10(11):2163-9. PubMed ID: 7784060
[TBL] [Abstract][Full Text] [Related]
33. Malignant transformation of human gastric epithelium cells via reactive oxygen species production and Wnt/β-catenin pathway activation following 40-week exposure to ochratoxin A.
Jia X; Cui J; Meng X; Xing L; Shen H; Wang J; Liu J; Wang Y; Lian W; Zhang X
Cancer Lett; 2016 Mar; 372(1):36-47. PubMed ID: 26721203
[TBL] [Abstract][Full Text] [Related]
34. Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice.
Saleem M; Afaq F; Adhami VM; Mukhtar H
Oncogene; 2004 Jul; 23(30):5203-14. PubMed ID: 15122342
[TBL] [Abstract][Full Text] [Related]
35. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
Dong Z; Birrer MJ; Watts RG; Matrisian LM; Colburn NH
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):609-13. PubMed ID: 8290571
[TBL] [Abstract][Full Text] [Related]
36. Antitumor progression potential of morusin suppressing STAT3 and NFκB in human hepatoma SK-Hep1 cells.
Lin WL; Lai DY; Lee YJ; Chen NF; Tseng TH
Toxicol Lett; 2015 Jan; 232(2):490-8. PubMed ID: 25476160
[TBL] [Abstract][Full Text] [Related]
37. Phosphatidylinositol-3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein 1 activation.
Huang C; Schmid PC; Ma WY; Schmid HH; Dong Z
J Biol Chem; 1997 Feb; 272(7):4187-94. PubMed ID: 9020132
[TBL] [Abstract][Full Text] [Related]
38. Four-day duration of tumor promoter exposure required to transform JB6 promotion-sensitive cells to anchorage independence.
Dion LD; Gindhart TD; Colburn NH
Cancer Res; 1988 Dec; 48(24 Pt 1):7126-31. PubMed ID: 3191489
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
40. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B.
Chung WY; Park JH; Kim MJ; Kim HO; Hwang JK; Lee SK; Park KK
Carcinogenesis; 2007 Jun; 28(6):1224-31. PubMed ID: 17234720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
